Canaccord lowered the firm’s price target on DocGo (DCGO) to $1.50 from $1.60 and keeps a Hold rating on the shares. The firm said while the price target does portend upside from current levels they believe that there is some value to be had for DocGo operations however, they do not see multiple expansion from a fundamental perspective until there is meaningful adj-EBITDA loss improvement.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCGO:
